Trial Profile
Study evaluating the efficacy of combination therapy of intravitreal ranibizumab and photodynamic therapy in patients with symptomatic retinal angiomatous proliferation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 29 Nov 2016 New trial record